Sign in

CIK 0001787306

  • Large accelerated filer

Arcutis Biotherapeutics, Inc.

Sign in to watch
Ticker
ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812974255
Phone
+1 805-418-5006
Business address
3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
Former names
Arcutis, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,253,826
in 9 filings, $2.1M under 10b5-1 plans

Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-04 Welgus Howard G. Director Exercise or conversion · Stock Option (right to buy) −6,458 0
2024-05-31 Matsuda Masaru Purchase +4,000 $1.69 $7K 185,373
2024-05-31 Watanabe Todd Franklin Purchase +4,000 $1.69 $7K 836,392
2024-05-30 Burnett Patrick Exercise or conversion +23,000 232,793
2024-05-30 Burnett Patrick Sale −23,000 $8.75 $201K 209,793
2024-05-30 Burnett Patrick Exercise or conversion · Stock Option (right to buy) −23,000 253,000
2024-05-29 Burnett Patrick Sale −49,952 $8.72 $435K 209,793
2024-05-28 Matsuda Masaru Sale 10b5-1 −1,775 $9.01 $16K 188,508
2024-05-27 Matsuda Masaru Grant or award 10b5-1 +4,875 190,283
2024-05-17 Edwards Larry Todd SVP Chief Commercial Officer Sale −7,640 $8.98 $69K 140,360
2024-05-16 Edwards Larry Todd SVP Chief Commercial Officer Grant or award +60,000 148,000
2024-05-02 Moore Matthew Richard SVP and Chief Business Officer Sale 10b5-1 −4,681 $8.74 $41K 145,505
2024-05-02 Watanabe Todd Franklin Sale 10b5-1 −13,783 $8.74 $120K 860,750
2024-05-02 Matsuda Masaru Sale 10b5-1 −5,016 $8.74 $44K 185,408
2024-05-02 Burnett Patrick Sale 10b5-1 −9,555 $8.74 $83K 259,745
2024-05-01 Moore Matthew Richard SVP and Chief Business Officer Grant or award 10b5-1 +4,166 150,186
2024-04-10 Topper David Joseph Chief Financial Officer Grant or award +110,000 110,000
2024-04-10 Topper David Joseph Chief Financial Officer Grant or award · Stock Option (right to buy) +310,000 310,000
2024-03-04 Matsuda Masaru Sale 10b5-1 −3,760 $11.12 $42K 190,424
2024-03-04 Burnett Patrick Sale 10b5-1 −4,782 $11.12 $53K 269,300

Page 19 of 35 · 689 trades